Details
Stereochemistry | UNKNOWN |
Molecular Formula | C28H36O6 |
Molecular Weight | 468.5818 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C)(OC1=CC=C(C=C1)C2(CCCCC2)C3=CC=C(OC(C)(CC)C(O)=O)C=C3)C(O)=O
InChI
InChIKey=BMOVQUBVGICXQN-UHFFFAOYSA-N
InChI=1S/C28H36O6/c1-5-26(3,24(29)30)33-22-14-10-20(11-15-22)28(18-8-7-9-19-28)21-12-16-23(17-13-21)34-27(4,6-2)25(31)32/h10-17H,5-9,18-19H2,1-4H3,(H,29,30)(H,31,32)
Molecular Formula | C28H36O6 |
Molecular Weight | 468.5818 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.google.com/patents/US20110269141
Sources: https://www.google.com/patents/US20110269141
Clinofibrate is known as a fibrate therapeutic drug for hyperlipidemia.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q07869 Gene ID: 5465.0 Gene Symbol: PPARA Target Organism: Homo sapiens (Human) Sources: http://www.springer.com/us/book/9781461475538 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | LIPOCLIN Approved UseIt is usually used to treat hyperlipidemia. |
PubMed
Title | Date | PubMed |
---|---|---|
Effects of some hypolipidemic agents on biochemical values and hepatic peroxisomal enzymes in rats: comparison of probucol, CGA, KCD-232, MLM-160, AL-369 and clinofibrate with clofibrate. | 1987 Mar |
|
[Usefulness of examination of the cholesterol versus triglyceride ratio for lipoprotein fractions in a patient with marked hyper-triglyceridemia]. | 2002 Oct |
|
Flow cytometric evaluation of synergistic pro-apoptotic effects of statins and clofibrates in IM-9 human lymphoblasts. | 2007 Sep |
|
4,4'-(Cyclo-hexane-1,1-di-yl)diphenol methanol solvate. | 2009 Jan 10 |
|
In vitro evaluation of inhibitory effects of antidiabetic and antihyperlipidemic drugs on human carboxylesterase activities. | 2010 Dec |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.229877.com/article/2013/0823/33410.html
For adults, take 1 tablet (200mg of the active ingredient) at a time, 3 times a day.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:09:56 GMT 2023
by
admin
on
Fri Dec 15 16:09:56 GMT 2023
|
Record UNII |
0374EZJ8CU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C98150
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB06666MIG
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
C006231
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
CLINOFIBRATE
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
CHEMBL1897738
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
680
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
DB09006
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
C78052
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
m3625
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000084296
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
DTXSID6046638
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
4421
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
30299-08-2
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
0374EZJ8CU
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY | |||
|
2787
Created by
admin on Fri Dec 15 16:09:56 GMT 2023 , Edited by admin on Fri Dec 15 16:09:56 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |